enkephalin-met, arg(6)-phe(7)- has been researched along with Pancreatic Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cheng, F; McLaughlin, PJ; Verderame, MF; Zagon, IS | 1 |
1 other study(ies) available for enkephalin-met, arg(6)-phe(7)- and Pancreatic Neoplasms
Article | Year |
---|---|
The OGF-OGFr axis utilizes the p21 pathway to restrict progression of human pancreatic cancer.
Topics: Blotting, Western; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase Inhibitor p21; Disease Progression; Enkephalin, Methionine; Flow Cytometry; Humans; Pancreatic Neoplasms; Receptors, Opioid; Retinoblastoma Protein; RNA, Small Interfering; Signal Transduction; Transfection | 2008 |